Stay updated on Cabozantinib in Salivary Gland Cancer: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.

Latest updates to the Cabozantinib in Salivary Gland Cancer: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 has been added. Notices about government funding and the prior Revision: v3.4.1 have been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding lapse and NIH operations status has been added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThe changes include showing the glossary (UI/help) and small wording/capitalization updates (Last Update Submitted that Met QC Criteria, No FEAR Act Data) along with a revision tag updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no new study information, endpoints, eligibility criteria, or contacts were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a dedicated Locations section with Gelderland as a location. Removed the old Gelderland Locations label and the HHS Vulnerability Disclosure.SummaryDifference0.2%

- Check91 days agoChange DetectedMinor wording changes related to the PubMed publications note and versioning were made. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Salivary Gland Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.